KOL Perspectives: Assessment and Management of Pain in Rheumatoid Arthritis
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
› The briefing includes analysis of KOL opinion on the following topic areas:
– Assessment of pain in RA clinical practice
– Management of pain in RA clinical practice
– Frequency, causes, and treatment of unresolved pain in RA
– Efficacy of cDMARDs & targeted therapies in treating RA pain
– Unmet needs in the management of pain in RA
Scope
› The insight briefing is based on Sociable Pharma’s analysis of primary research with our rheumatoid arthritis key opinion leaders (KOLs)
› In total, we conducted interviews with 10 KOLs:
– Five Europe-based & five US-based
– Interviews performed during Jul 2017
> KOL data is analyzed to produce:
– Charts summarizing KOL opinions
– Chart call-outs of key information & details
– KOL quotes
– Summary of KOL reporting trends
– Insight from Sociable Pharma's analysts
Key Highlights
While KOLs appear to regard pain as an important symptom of RA, there is considerable variation in how it is assessed in clinical practice
The leading strategy used by KOLs to alleviate pain is to focus on reducing disease activity & inflammation
Patients who have achieved low disease activity or remission frequently continue to report pain
Reasons to Buy
Combines Qualitative & semi-quantitative insight from key opinion leaders on " Assessment and Management of Pain in Rheumatoid Arthritis "
Includes insight & recommendations from our disease-specific healthcare analysts
Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of rheumatoid arthritis
Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Immunology reports